Join our exploration of vital oncology topics, including caring for cancer survivors, AI in patient care, the future of CAR-T therapies, and the rise of targeted radiopharmaceuticals.
Innovative designs, accelerated early-stage research, novel drug classes, advanced imaging, and personalised treatment optimisation are reshaping the oncology trial landscape, as Advanced Clinical's Dr Ravi Karra explains.
Vikram Gosain from Putnam (an Inizio Advisory company) explores the transformative impact of targeted radiopharmaceuticals in cancer treatment, highlighting successes, emerging trends, and industry challenges.
